Ann: IHL-42X positive phase 2 clinical trial results, page-132

It looks like the trial participant count being low is the primary reason why there are sellers. 11 participants is quite low, but it's understandable considering the Covid situation in Australia was quite grim.

I do realize that once approval comes in for larger trials here in the US of A, we will see this thing pop off big time. At this point in time it would be recommended to sit back and enjoy buying more at these lower prices instead of dreading on the SP dropping.

This is why the saying buy the rumor, sell the news exists. We experienced it. What happens until the next rumors start swirling will lead us past that $1+ mark, guaranteed.